Closing in on 10 months

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Closing in on 10 months

posted on Jun 18, 2017 07:05PM

If my previous posts were anywhere close to the mark for the longest survivor on ZEN3694 Mono Cohorts then we should be hitting the 10 month mark some time this week. Haven't heard to much about the combination trial and how it is going. Maybe we will hear something in the update this week at BioInternational.